Axem Neurotechnology
PrivateLast Round
Grant
Sep 19, 2023
Total Funding Raised
$1.93M
Company Overview
Axem Neurotechnology operates in Healthcare & Life Sciences and is based in Halifax. Its latest recorded funding round was a Grant round in September 2023.
Axem Neurotechnology is a medical technology company that develops portable neuroimaging systems and brain-sensing headsets to assist in neurological rehabilitation and motor recovery for stroke patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Telemedicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axem Neurotechnology Comparables
Compare Axem Neurotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kandu Health | 77% | |
| BrainQ Technologies | 74% | |
| Kernel | 69% |
For institutional investors. Book with your work email.
Axem Neurotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 19, 2023 | ||||
| Grant | Jun 1, 2023 | ||||
| Seed | Mar 31, 2023 | ||||
| Debt | Dec 7, 2022 | ||||
| Grant | Sep 29, 2022 | ||||
Grant | Sep 24, 2021 |
For institutional investors. Book with your work email.
Axem Neurotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovacorp | Seed, Grant |
| Innovacorp | Seed, Grant |
| Ontario Brain Institute | Grant |
| Atlantic Canada Opportunities Agency | Debt, Grant |
| National Research Council Canada | Grant, Accelerator |
| Berkeley SkyDeck | Accelerator |
| National Research Council of Canada | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 19, 2023
$74K grant received from Ontario Brain Institute.
- Jun 1, 2023
$150K grant received from the National Research Council of Canada.
For institutional investors. Book with your work email.
Axem Neurotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Axem Neurotechnology's valuation, stock price, and market status.
Is Axem Neurotechnology a public or private company?
Axem Neurotechnology is a private company.
What is the current stock price of Axem Neurotechnology?
Axem Neurotechnology is a private company, so its shares have no public market price. Caplight tracks Axem Neurotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Axem Neurotechnology worth (valuation)?
Valuation information for Axem Neurotechnology is not publicly available.
Can I buy Axem Neurotechnology stock?
Axem Neurotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Axem Neurotechnology's last funding round?
Axem Neurotechnology's most recent funding round was Grant on September 19, 2023.
Who are the main investors in Axem Neurotechnology?
Key investors in Axem Neurotechnology include HAX.
Will Axem Neurotechnology IPO soon?
No public IPO plans have been announced for Axem Neurotechnology.
How can I track Axem Neurotechnology secondary market activity?
Caplight tracks bids, offers, and trades in Axem Neurotechnology's shares on secondary markets.